Deleted Tweet from Scott Gottlieb, R-D.C.
Deleted Tweet from Scott Gottlieb, M.D.
SteveFDA (R-D.C.)
@SGottliebFDA
Politwoops no longer follows this account.
4/5 Today’s action builds on another draft guidance issued in April regarding drug development and trial design issues relevant to the study of depot buprenorphine products (i.e., modified-release products for injection or implantation) for OUD: https://t.co/onLB1n57PH
It looks like this tweet was replaced by the next tweet from @SGottliebFDA.